Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Artificial Intelligence In Pathology Market Expansion Outlook: What Revenue Opportunities Lie Ahead?
The market for artificial intelligence in pathology has experienced significant expansion in recent times. From $1.38 billion in 2025, it is projected to rise to $1.57 billion in 2026, reflecting a compound annual growth rate (CAGR) of 13.4%. Historical growth was driven by several factors, including the ongoing digitization of pathology workflows, a heightened need for precise cancer diagnostic tools, the broadening of pharmaceutical research initiatives, the widespread use of digital slide scanners, and an increasing supply of medical imaging data sets.
The artificial intelligence in pathology market is projected to experience significant growth over the coming years, with an anticipated increase to $2.57 billion by 2030 at a compound annual growth rate (CAGR) of 13.2%. This forecasted expansion is driven by several factors, including the growing adoption of AI-assisted diagnostics, an intensified emphasis on personalized medicine, broader integration of AI into clinical decision support systems, increased investment in digital healthcare infrastructure, and a rising number of regulatory approvals for AI-powered pathology tools. Key trends shaping the market during this period include the widespread uptake of AI-based digital pathology platforms, the growing application of deep learning techniques for tumor detection, the expanded use of whole slide imaging systems, the enhancement of predictive analytics in disease diagnosis, and a stronger focus on automating workflows within pathology laboratories.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18960&type=smp
Artificial Intelligence In Pathology Market Opportunity Drivers: What Is Creating New Revenue Potential?
The rising demand for tailored medical approaches is expected to drive the expansion of the artificial intelligence in pathology market in the coming years. Personalized medicine involves customizing medical care and treatments based on the unique characteristics, needs, and preferences of each patient. This growing demand stems from the ability to adapt therapies to individual genetic profiles, lifestyle factors, and specific disease traits, which enhances treatment effectiveness and minimizes unwanted side effects. Artificial intelligence in pathology supports personalized medicine by facilitating more precise and efficient interpretation of medical images and genetic information, enabling better diagnostic accuracy, improved detection of disease variants, and the development of treatment strategies tailored to a person’s specific biological makeup. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based professional organization, reported that the US Food and Drug Administration (FDA) approved 20 new personalized medicines in 2023, representing around 38% of all newly authorized therapeutic molecular entities—a notable rise compared to earlier years. Consequently, the increasing emphasis on personalized medicine is fueling growth in the artificial intelligence in pathology market.
Artificial Intelligence In Pathology Market Segment Analysis And Revenue Opportunities
The artificial intelligence in pathology market covered in this report is segmented –
1) By Component: Software, Scanners
2) By Neural Network: Generative Adversarial Networks, Convolutional Neural Networks, Conventional Neural Network, Recurrent Neural Networks, Other Neural Networks
3) By Application: Drug Discovery, Disease Diagnosis And Prognosis, Clinical Workflow, Training And Education
4) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Reference Laboratories, Academic And Research Institutes
Subsegments:
1) By Software: Image Analysis Software, Diagnostic Workflow Software, Predictive Analytics Software
2) By Scanners: Whole Slide Imaging Scanners, Digital Pathology Scanners, Multi-Spectral Imaging Scanners
Artificial Intelligence In Pathology Market Innovation Trends Driving Future Development
Major players within the AI pathology market are placing significant emphasis on creating advanced diagnostic solutions, particularly multi-tissue cancer detection systems, with the goal of elevating diagnostic precision, optimizing workflow efficiency, and ultimately delivering superior patient outcomes. These AI-driven multi-tissue cancer detection tools rely on foundation models and deep-learning algorithms to assess digitized pathology slides, facilitating cancer identification across a wide range of tissue types, which includes uncommon tumors and metastatic growths. For example, in January 2024, Paige, a digital pathology firm headquartered in the United States, unveiled a novel AI application built upon its Virchow foundation model. This tool is capable of identifying cancerous growths in over 17 distinct tissue categories. Pathologists are expected to benefit from enhanced diagnostic precision, quicker workflow processes, and actionable insights that support tailored patient care through the use of this solution.
Artificial Intelligence In Pathology Market Leading Players Shaping Industry Direction
Major companies operating in the artificial intelligence in pathology market are F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Hamamatsu Photonics K.K., Leica Biosystems, Tempus Labs Inc., Spectra AB, Lunit Inc., Paige AI Inc., Inspirata Inc., Indica Labs Inc., Flagship Biosciences Inc, Proscia Inc., Aiforia Technologies Oy, Lumea Inc., Optrascan Inc., PathAI Inc., Visiopharm A/S, Ibex Medical Analytics Ltd., BioSymetrics Inc., Deep Bio Inc., Konfoong Biotech International Co Ltd., Mindpeak GmbH, Qritive Inc., Vuno Inc.
Access The Complete Artificial Intelligence In Pathology Market Report:
Artificial Intelligence In Pathology Market Geographic Analysis: Where Is Demand Growing The Fastest?
Asia-Pacific was the largest region in the artificial intelligence in pathology market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in pathology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Artificial Intelligence In Pathology Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=18960&type=smp
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.